Industry Research Reports

Home > Reports > Medical Devices & Consumables > Liver Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Liver Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published: 2024-01-18

Pages: 107 Pages

Report ld: 2328111

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The liver is an organ about the size of a football. It sits just under your rib cage on the right side of your abdomen. The liver is essential for digesting food and ridding your body of toxic substances. Liver disease can be inherited (genetic). Liver problems can also be caused by a variety of factors that damage the liver, such as viruses, alcohol use and obesity. Over time, conditions that damage the liver can lead to scarring (cirrhosis), which can lead to liver failure, a life-threatening condition. But early treatment may give the liver time to heal.

There are multiple causes of liver disease. While some are infective, some are genetic or autoimmune and some metabolic. This makes diagnosis difficult and often there are a battery of tests that need to be performed in order to correctly diagnose the underlying cause for the disease. Blood tests, biopsy and imaging tests are often used to check for liver disease.

Liver Disease Diagnostics Market Size

M= millions and B=billions

The global market for Liver Disease Diagnostics was estimated to be worth US$ 12260 million in 2023 and is forecast to a readjusted size of US$ 20110 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030
Global key players of Liver Disease Diagnostics include Abbott, Roche and Thermo Fisher Scientific, etc. The top three players hold a share over 15%. North America is the largest market, has a share about 40%. In terms of product type, Imaging Tests is the largest segment, occupied for a share of about 60%, and in terms of application, Hospitals and Clinics has a share about 72 percent.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liver Disease Diagnostics by region & country, by Purity, and by Application.

The Liver Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Disease Diagnostics.

Market Segmentation

Report Metric
Details
Report Title
Liver Disease Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 20110 million
CAGR(2024-2030)
7.1%
Market Size Available for Years
2019-2030
Global Liver Disease Diagnostics Companies Covered
Abbott, Roche, Thermo Fisher Scientific, Randox Laboratories, Boston Scientific, LabCorp, Fujifilm Corporation, Siemens Healthineers, BD, Cook Medical, GE Healthcare, Philips Healthcare, Canon Medical Systems, Qiagen
Global Liver Disease Diagnostics Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Liver Disease Diagnostics Market, Segment by Type
Imaging Tests

Blood Tests

Biopsy
Global Liver Disease Diagnostics Market, Segment by Application
Hospitals and Clinics

Diagnostic Centers

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Liver Disease Diagnostics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Liver Disease Diagnostics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Liver Disease Diagnostics in country level. It provides sigmate data by Purity, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Liver Disease Diagnostics Product Introduction
    1.2 Global Liver Disease Diagnostics Market Size Forecast
    1.3 Liver Disease Diagnostics Market Trends & Drivers
        1.3.1 Liver Disease Diagnostics Industry Trends
        1.3.2 Liver Disease Diagnostics Market Drivers & Opportunity
        1.3.3 Liver Disease Diagnostics Market Challenges
        1.3.4 Liver Disease Diagnostics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Liver Disease Diagnostics Players Revenue Ranking (2023)
    2.2 Global Liver Disease Diagnostics Revenue by Company (2019-2024)
    2.3 Key Companies Liver Disease Diagnostics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Liver Disease Diagnostics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Liver Disease Diagnostics
    2.6 Liver Disease Diagnostics Market Competitive Analysis
        2.6.1 Liver Disease Diagnostics Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Liver Disease Diagnostics Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Disease Diagnostics as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Purity
    3.1 Introduction by Purity
        3.1.1 Imaging Tests
        3.1.2 Blood Tests
        3.1.3 Biopsy
    3.2 Global Liver Disease Diagnostics Sales Value by Purity
        3.2.1 Global Liver Disease Diagnostics Sales Value by Purity (2019 VS 2023 VS 2030)
        3.2.2 Global Liver Disease Diagnostics Sales Value, by Purity (2019-2030)
        3.2.3 Global Liver Disease Diagnostics Sales Value, by Purity (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals and Clinics
        4.1.2 Diagnostic Centers
        4.1.3 Others
    4.2 Global Liver Disease Diagnostics Sales Value by Application
        4.2.1 Global Liver Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Liver Disease Diagnostics Sales Value, by Application (2019-2030)
        4.2.3 Global Liver Disease Diagnostics Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Liver Disease Diagnostics Sales Value by Region
        5.1.1 Global Liver Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Liver Disease Diagnostics Sales Value by Region (2019-2024)
        5.1.3 Global Liver Disease Diagnostics Sales Value by Region (2025-2030)
        5.1.4 Global Liver Disease Diagnostics Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Liver Disease Diagnostics Sales Value, 2019-2030
        5.2.2 North America Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Liver Disease Diagnostics Sales Value, 2019-2030
        5.3.2 Europe Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Liver Disease Diagnostics Sales Value, 2019-2030
        5.4.2 Asia Pacific Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Liver Disease Diagnostics Sales Value, 2019-2030
        5.5.2 South America Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Liver Disease Diagnostics Sales Value, 2019-2030
        5.6.2 Middle East & Africa Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Liver Disease Diagnostics Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Liver Disease Diagnostics Sales Value
    6.3 United States
        6.3.1 United States Liver Disease Diagnostics Sales Value, 2019-2030
        6.3.2 United States Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.3.3 United States Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Liver Disease Diagnostics Sales Value, 2019-2030
        6.4.2 Europe Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.4.3 Europe Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Liver Disease Diagnostics Sales Value, 2019-2030
        6.5.2 China Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.5.3 China Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Liver Disease Diagnostics Sales Value, 2019-2030
        6.6.2 Japan Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.6.3 Japan Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Liver Disease Diagnostics Sales Value, 2019-2030
        6.7.2 South Korea Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.7.3 South Korea Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Liver Disease Diagnostics Sales Value, 2019-2030
        6.8.2 Southeast Asia Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.8.3 Southeast Asia Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Liver Disease Diagnostics Sales Value, 2019-2030
        6.9.2 India Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
        6.9.3 India Liver Disease Diagnostics Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Profile
        7.1.2 Abbott Main Business
        7.1.3 Abbott Liver Disease Diagnostics Products, Services and Solutions
        7.1.4 Abbott Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.1.5 Abbott Recent Developments
    7.2 Roche
        7.2.1 Roche Profile
        7.2.2 Roche Main Business
        7.2.3 Roche Liver Disease Diagnostics Products, Services and Solutions
        7.2.4 Roche Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.2.5 Roche Recent Developments
    7.3 Thermo Fisher Scientific
        7.3.1 Thermo Fisher Scientific Profile
        7.3.2 Thermo Fisher Scientific Main Business
        7.3.3 Thermo Fisher Scientific Liver Disease Diagnostics Products, Services and Solutions
        7.3.4 Thermo Fisher Scientific Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.3.5 Randox Laboratories Recent Developments
    7.4 Randox Laboratories
        7.4.1 Randox Laboratories Profile
        7.4.2 Randox Laboratories Main Business
        7.4.3 Randox Laboratories Liver Disease Diagnostics Products, Services and Solutions
        7.4.4 Randox Laboratories Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.4.5 Randox Laboratories Recent Developments
    7.5 Boston Scientific
        7.5.1 Boston Scientific Profile
        7.5.2 Boston Scientific Main Business
        7.5.3 Boston Scientific Liver Disease Diagnostics Products, Services and Solutions
        7.5.4 Boston Scientific Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.5.5 Boston Scientific Recent Developments
    7.6 LabCorp
        7.6.1 LabCorp Profile
        7.6.2 LabCorp Main Business
        7.6.3 LabCorp Liver Disease Diagnostics Products, Services and Solutions
        7.6.4 LabCorp Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.6.5 LabCorp Recent Developments
    7.7 Fujifilm Corporation
        7.7.1 Fujifilm Corporation Profile
        7.7.2 Fujifilm Corporation Main Business
        7.7.3 Fujifilm Corporation Liver Disease Diagnostics Products, Services and Solutions
        7.7.4 Fujifilm Corporation Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.7.5 Fujifilm Corporation Recent Developments
    7.8 Siemens Healthineers
        7.8.1 Siemens Healthineers Profile
        7.8.2 Siemens Healthineers Main Business
        7.8.3 Siemens Healthineers Liver Disease Diagnostics Products, Services and Solutions
        7.8.4 Siemens Healthineers Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.8.5 Siemens Healthineers Recent Developments
    7.9 BD
        7.9.1 BD Profile
        7.9.2 BD Main Business
        7.9.3 BD Liver Disease Diagnostics Products, Services and Solutions
        7.9.4 BD Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.9.5 BD Recent Developments
    7.10 Cook Medical
        7.10.1 Cook Medical Profile
        7.10.2 Cook Medical Main Business
        7.10.3 Cook Medical Liver Disease Diagnostics Products, Services and Solutions
        7.10.4 Cook Medical Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.10.5 Cook Medical Recent Developments
    7.11 GE Healthcare
        7.11.1 GE Healthcare Profile
        7.11.2 GE Healthcare Main Business
        7.11.3 GE Healthcare Liver Disease Diagnostics Products, Services and Solutions
        7.11.4 GE Healthcare Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.11.5 GE Healthcare Recent Developments
    7.12 Philips Healthcare
        7.12.1 Philips Healthcare Profile
        7.12.2 Philips Healthcare Main Business
        7.12.3 Philips Healthcare Liver Disease Diagnostics Products, Services and Solutions
        7.12.4 Philips Healthcare Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.12.5 Philips Healthcare Recent Developments
    7.13 Canon Medical Systems
        7.13.1 Canon Medical Systems Profile
        7.13.2 Canon Medical Systems Main Business
        7.13.3 Canon Medical Systems Liver Disease Diagnostics Products, Services and Solutions
        7.13.4 Canon Medical Systems Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.13.5 Canon Medical Systems Recent Developments
    7.14 Qiagen
        7.14.1 Qiagen Profile
        7.14.2 Qiagen Main Business
        7.14.3 Qiagen Liver Disease Diagnostics Products, Services and Solutions
        7.14.4 Qiagen Liver Disease Diagnostics Revenue (US$ Million) & (2019-2024)
        7.14.5 Qiagen Recent Developments

 8 Industry Chain Analysis
    8.1 Liver Disease Diagnostics Industrial Chain
    8.2 Liver Disease Diagnostics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Liver Disease Diagnostics Sales Model
        8.5.2 Sales Channel
        8.5.3 Liver Disease Diagnostics Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Liver Disease Diagnostics Market Trends
    Table 2. Liver Disease Diagnostics Market Drivers & Opportunity
    Table 3. Liver Disease Diagnostics Market Challenges
    Table 4. Liver Disease Diagnostics Market Restraints
    Table 5. Global Liver Disease Diagnostics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Liver Disease Diagnostics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Liver Disease Diagnostics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Liver Disease Diagnostics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Liver Disease Diagnostics
    Table 10. Global Liver Disease Diagnostics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Disease Diagnostics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Liver Disease Diagnostics Sales Value by Purity: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Liver Disease Diagnostics Sales Value by Purity (2019-2024) & (US$ Million)
    Table 15. Global Liver Disease Diagnostics Sales Value by Purity (2025-2030) & (US$ Million)
    Table 16. Global Liver Disease Diagnostics Sales Market Share in Value by Purity (2019-2024) & (%)
    Table 17. Global Liver Disease Diagnostics Sales Market Share in Value by Purity (2025-2030) & (%)
    Table 18. Global Liver Disease Diagnostics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Liver Disease Diagnostics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Liver Disease Diagnostics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Liver Disease Diagnostics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Liver Disease Diagnostics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Liver Disease Diagnostics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Liver Disease Diagnostics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Liver Disease Diagnostics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Liver Disease Diagnostics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Liver Disease Diagnostics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Liver Disease Diagnostics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Liver Disease Diagnostics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Liver Disease Diagnostics Sales Value, (2025-2030) & (US$ Million)
    Table 31. Abbott Basic Information List
    Table 32. Abbott Description and Business Overview
    Table 33. Abbott Liver Disease Diagnostics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Liver Disease Diagnostics Business of Abbott (2019-2024)
    Table 35. Abbott Recent Developments
    Table 36. Roche Basic Information List
    Table 37. Roche Description and Business Overview
    Table 38. Roche Liver Disease Diagnostics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Liver Disease Diagnostics Business of Roche (2019-2024)
    Table 40. Roche Recent Developments
    Table 41. Thermo Fisher Scientific Basic Information List
    Table 42. Thermo Fisher Scientific Description and Business Overview
    Table 43. Thermo Fisher Scientific Liver Disease Diagnostics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Liver Disease Diagnostics Business of Thermo Fisher Scientific (2019-2024)
    Table 45. Thermo Fisher Scientific Recent Developments
    Table 46. Randox Laboratories Basic Information List
    Table 47. Randox Laboratories Description and Business Overview
    Table 48. Randox Laboratories Liver Disease Diagnostics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Liver Disease Diagnostics Business of Randox Laboratories (2019-2024)
    Table 50. Randox Laboratories Recent Developments
    Table 51. Boston Scientific Basic Information List
    Table 52. Boston Scientific Description and Business Overview
    Table 53. Boston Scientific Liver Disease Diagnostics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Liver Disease Diagnostics Business of Boston Scientific (2019-2024)
    Table 55. Boston Scientific Recent Developments
    Table 56. LabCorp Basic Information List
    Table 57. LabCorp Description and Business Overview
    Table 58. LabCorp Liver Disease Diagnostics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Liver Disease Diagnostics Business of LabCorp (2019-2024)
    Table 60. LabCorp Recent Developments
    Table 61. Fujifilm Corporation Basic Information List
    Table 62. Fujifilm Corporation Description and Business Overview
    Table 63. Fujifilm Corporation Liver Disease Diagnostics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Liver Disease Diagnostics Business of Fujifilm Corporation (2019-2024)
    Table 65. Fujifilm Corporation Recent Developments
    Table 66. Siemens Healthineers Basic Information List
    Table 67. Siemens Healthineers Description and Business Overview
    Table 68. Siemens Healthineers Liver Disease Diagnostics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Liver Disease Diagnostics Business of Siemens Healthineers (2019-2024)
    Table 70. Siemens Healthineers Recent Developments
    Table 71. BD Basic Information List
    Table 72. BD Description and Business Overview
    Table 73. BD Liver Disease Diagnostics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Liver Disease Diagnostics Business of BD (2019-2024)
    Table 75. BD Recent Developments
    Table 76. Cook Medical Basic Information List
    Table 77. Cook Medical Description and Business Overview
    Table 78. Cook Medical Liver Disease Diagnostics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Liver Disease Diagnostics Business of Cook Medical (2019-2024)
    Table 80. Cook Medical Recent Developments
    Table 81. GE Healthcare Basic Information List
    Table 82. GE Healthcare Description and Business Overview
    Table 83. GE Healthcare Liver Disease Diagnostics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Liver Disease Diagnostics Business of GE Healthcare (2019-2024)
    Table 85. GE Healthcare Recent Developments
    Table 86. Philips Healthcare Basic Information List
    Table 87. Philips Healthcare Description and Business Overview
    Table 88. Philips Healthcare Liver Disease Diagnostics Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Liver Disease Diagnostics Business of Philips Healthcare (2019-2024)
    Table 90. Philips Healthcare Recent Developments
    Table 91. Canon Medical Systems Basic Information List
    Table 92. Canon Medical Systems Description and Business Overview
    Table 93. Canon Medical Systems Liver Disease Diagnostics Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Liver Disease Diagnostics Business of Canon Medical Systems (2019-2024)
    Table 95. Canon Medical Systems Recent Developments
    Table 96. Qiagen Basic Information List
    Table 97. Qiagen Description and Business Overview
    Table 98. Qiagen Liver Disease Diagnostics Products, Services and Solutions
    Table 99. Revenue (US$ Million) in Liver Disease Diagnostics Business of Qiagen (2019-2024)
    Table 100. Qiagen Recent Developments
    Table 101. Key Raw Materials Lists
    Table 102. Raw Materials Key Suppliers Lists
    Table 103. Liver Disease Diagnostics Downstream Customers
    Table 104. Liver Disease Diagnostics Distributors List
    Table 105. Research Programs/Design for This Report
    Table 106. Key Data Information from Secondary Sources
    Table 107. Key Data Information from Primary Sources
    Table 108. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Liver Disease Diagnostics Product Picture
    Figure 2. Global Liver Disease Diagnostics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Liver Disease Diagnostics Report Years Considered
    Figure 5. Global Liver Disease Diagnostics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Liver Disease Diagnostics Revenue in 2023
    Figure 7. Liver Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Imaging Tests Picture
    Figure 9. Blood Tests Picture
    Figure 10. Biopsy Picture
    Figure 11. Global Liver Disease Diagnostics Sales Value by Purity (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 12. Global Liver Disease Diagnostics Sales Value Market Share by Purity, 2023 & 2030
    Figure 13. Product Picture of Hospitals and Clinics
    Figure 14. Product Picture of Diagnostic Centers
    Figure 15. Product Picture of Others
    Figure 16. Global Liver Disease Diagnostics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Liver Disease Diagnostics Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Liver Disease Diagnostics Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Liver Disease Diagnostics Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Liver Disease Diagnostics Sales Value (%), (2019-2030)
    Figure 29. United States Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 31. United States Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 34. Europe Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 37. China Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 40. Japan Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 43. South Korea Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 46. Southeast Asia Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Liver Disease Diagnostics Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Liver Disease Diagnostics Sales Value by Purity (%), 2023 VS 2030
    Figure 49. India Liver Disease Diagnostics Sales Value by Application (%), 2023 VS 2030
    Figure 50. Liver Disease Diagnostics Industrial Chain
    Figure 51. Liver Disease Diagnostics Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

The liver is an organ about the size of a football. It sits just under your rib cage on the right side of your abdomen. The liver is essential for digesting food and ridding your body of toxic substances. Liver disease can be inherited (genetic). Liver problems can also be caused by a variety of factors that damage the liver, such as viruses, alcohol use and obesity. Over time, conditions that damage the liver can lead to scarring (cirrhosis), which can lead to liver failure, a life-threatening condition. But early treatment may give the liver time to heal.

There are multiple causes of liver disease. While some are infective, some are genetic or autoimmune and some metabolic. This makes diagnosis difficult and often there are a battery of tests that need to be performed in order to correctly diagnose the underlying cause for the disease. Blood tests, biopsy and imaging tests are often used to check for liver disease.

The global market for Liver Disease Diagnostics was estimated to be worth US$ 12260 million in 2023 and is forecast to a readjusted size of US$ 20110 million by 2030 with a CAGR of 7.1% during the forecast period 2024-2030
Global key players of Liver Disease Diagnostics include Abbott, Roche and Thermo Fisher Scientific, etc. The top three players hold a share over 15%. North America is the largest market, has a share about 40%. In terms of product type, Imaging Tests is the largest segment, occupied for a share of about 60%, and in terms of application, Hospitals and Clinics has a share about 72 percent.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Liver Disease Diagnostics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Liver Disease Diagnostics by region & country, by Purity, and by Application.

The Liver Disease Diagnostics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Disease Diagnostics.

Market Segmentation